HPLC assay for determination of rebamipide in plasma and its pharmacokinetic investigation

Chinese Pharmaceutical Journal

Volumn 34, Issue 6, 1999, Pages 396-399

  Zhao, Rongsheng ^a   Duan, Jingli ^a   Yan, Baoxia ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

HPLC; Pharmacokinetics; Rebamipide

Indexed keywords

ACETIC ACID ETHYL ESTER; BUFFER; METHANOL; PHOSPHATE; REBAMIPIDE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ULTRAVIOLET SPECTROSCOPY;

EID: 0032795341     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Japan Medical Products International Trade Association. Japan Pharmaceutical Reference , ed4 Tokyo: Tanaka Printing CO. Ltd. , 1996:689-692.
2. Yuji Naito, Toshikazu Yoshikawa, Shoji Iinuma, et al. Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis. Arzneim-Forsch /Drug Res , 1996, 46( II ):698.
3. Yoshihide Shioya, Takefumi Shimizu. High-performance liquid chromatographic procedure for the determination of new anti-gastric ulcer agent, 2-(4-chlorobenzoylamino)-3-[2 (IH)-quinolinon-4-yl] propionic acid, in human plasma and urine. J Chromatogr , 1988, 434:283.